187 related articles for article (PubMed ID: 24356192)
1. Differential expression of degradome components in cutaneous squamous cell carcinomas.
Prasad NB; Fischer AC; Chuang AY; Wright JM; Yang T; Tsai HL; Westra WH; Liegeois NJ; Hess AD; Tufaro AP
Mod Pathol; 2014 Jul; 27(7):945-57. PubMed ID: 24356192
[TBL] [Abstract][Full Text] [Related]
2. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.
Stokes A; Joutsa J; Ala-Aho R; Pitchers M; Pennington CJ; Martin C; Premachandra DJ; Okada Y; Peltonen J; Grénman R; James HA; Edwards DR; Kähäri VM
Clin Cancer Res; 2010 Apr; 16(7):2022-35. PubMed ID: 20305301
[TBL] [Abstract][Full Text] [Related]
3. Expression of reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase 9 in middle ear squamous cell carcinoma.
Liu X; Wang W; Chen J; Chen C; Zhou J; Cao L
ORL J Otorhinolaryngol Relat Spec; 2012; 74(1):16-21. PubMed ID: 22178867
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase 1: a better biomarker for squamous cell carcinoma by multiple microarray analyses.
Zheng LQ; Wang R; Chi SM; Li CX
G Ital Dermatol Venereol; 2019 Jun; 154(3):327-337. PubMed ID: 29249121
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of human cutaneous squamous cell carcinoma from tissues and cell lines identified by DNA microarrays and qRT-PCR.
Dooley TP; Reddy SP; Wilborn TW; Davis RL
Biochem Biophys Res Commun; 2003 Jul; 306(4):1026-36. PubMed ID: 12821146
[TBL] [Abstract][Full Text] [Related]
7. Complement factor I upregulates expression of matrix metalloproteinase-13 and -2 and promotes invasion of cutaneous squamous carcinoma cells.
Rahmati Nezhad P; Riihilä P; Piipponen M; Kallajoki M; Meri S; Nissinen L; Kähäri VM
Exp Dermatol; 2021 Nov; 30(11):1631-1641. PubMed ID: 33813765
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA Expression Profiling of Cutaneous Squamous Cell Carcinomas Arising in Different Sites.
Rock AN; Fisher MD; Amborski G; Allain DC; Klee V; Peters SB; Kang S; Toland AE
Otolaryngol Head Neck Surg; 2020 Sep; 163(3):538-545. PubMed ID: 32423289
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway.
Dong G; Loukinova E; Chen Z; Gangi L; Chanturita TI; Liu ET; Van Waes C
Cancer Res; 2001 Jun; 61(12):4797-808. PubMed ID: 11406555
[TBL] [Abstract][Full Text] [Related]
10. MAGEA3 Expression in Cutaneous Squamous Cell Carcinoma Is Associated with Advanced Tumor Stage and Poor Prognosis.
Abikhair M; Roudiani N; Mitsui H; Krueger JG; Pavlick A; Lee J; Therrien JP; Meehan SA; Felsen D; Carucci JA
J Invest Dermatol; 2017 Mar; 137(3):775-778. PubMed ID: 27826009
[No Abstract] [Full Text] [Related]
11. Retinoblastoma gene expression in human non-melanoma skin cancer.
Edwards MJ; Thomas RC; Wong YL
J Cutan Pathol; 2003 Sep; 30(8):479-85. PubMed ID: 12950498
[TBL] [Abstract][Full Text] [Related]
12. p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling.
Piipponen M; Nissinen L; Riihilä P; Farshchian M; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
Am J Pathol; 2020 Feb; 190(2):503-517. PubMed ID: 31837949
[TBL] [Abstract][Full Text] [Related]
13. The matrix metalloproteinase gene family: a significant prognostic gene lineage correlated with immune infiltrates in laryngeal squamous cell carcinoma.
Yang C; Cao H; Yang JW; Liu T; Wang JT; Wang BS
Neoplasma; 2021 Nov; 68(6):1212-1224. PubMed ID: 34585589
[TBL] [Abstract][Full Text] [Related]
14. Metastasis suppressor proteins in cutaneous squamous cell carcinoma.
Bozdogan O; Vargel I; Cavusoglu T; Karabulut AA; Karahan G; Sayar N; Atasoy P; Yulug IG
Pathol Res Pract; 2016 Jul; 212(7):608-15. PubMed ID: 27215390
[TBL] [Abstract][Full Text] [Related]
15. Reversion-inducing cysteine-rich protein with Kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer.
Pramanik KK; Singh AK; Alam M; Kashyap T; Mishra P; Panda AK; Dey RK; Rana A; Nagini S; Mishra R
Tumour Biol; 2016 Nov; 37(11):15253-15264. PubMed ID: 27696293
[TBL] [Abstract][Full Text] [Related]
16. Differentiating cutaneous squamous cell carcinoma and pseudoepitheliomatous hyperplasia by multiplex qRT-PCR.
Su A; Ra S; Li X; Zhou J; Binder S
Mod Pathol; 2013 Nov; 26(11):1433-7. PubMed ID: 23702732
[TBL] [Abstract][Full Text] [Related]
17. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
[TBL] [Abstract][Full Text] [Related]
18. Overexpression and Implications of Melanoma-associated Antigen A12 in Pathogenesis of Human Cutaneous Squamous Cell Carcinoma.
Zhao G; Bae JY; Zheng Z; Park HS; Chung KY; Roh MR; Jin Z
Anticancer Res; 2019 Apr; 39(4):1849-1857. PubMed ID: 30952725
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of the leading edge of cutaneous squamous cell carcinoma: IL-24-driven MMP-7.
Mitsui H; Suárez-Fariñas M; Gulati N; Shah KR; Cannizzaro MV; Coats I; Felsen D; Krueger JG; Carucci JA
J Invest Dermatol; 2014 May; 134(5):1418-1427. PubMed ID: 24270662
[TBL] [Abstract][Full Text] [Related]
20. Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers.
Hida Y; Hamada J
Anticancer Agents Med Chem; 2012 Sep; 12(7):744-52. PubMed ID: 22292754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
